Clinical Trials Browser

Phase 1 × von Hippel-Lindau Disease × Genitourinary × Clear all

NCT04895748 2026-03-03

DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies

Phase 1 Terminated

CNSEndocrineGenitourinary

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell, von Hippel-Lindau Disease, Paraganglioma, Pheochromocytoma

NCT05843305 2023-05-06

A Study of BPI-452080 in Subjects With Solid Tumors

Phase 1 Unknown

Carcinoma, Renal Cell, von Hippel-Lindau Disease